TIDMGHG

RNS Number : 7518N

Georgia Healthcare Group PLC

11 August 2017

London, 11 August 2017

Georgia Healthcare Group PLC notice of 2Q and 1H 2017 Results

Georgia Healthcare Group PLC ("GHG") will publish its financial results for 2Q and 1H 2017 at 07:00 London time on Tuesday, 15 August 2017. The results announcement will be available on GHG's website at ghg.com.ge. An investor/analyst conference call, organised by GHG, will be held on Tuesday, 15 August 2017, at 14:00 UK / 15:00 CET / 09:00 U.S Eastern Time. The duration of the call will be 60 minutes and will consist of a 15-minute update and a 45-minute Q&A session.

 
 Dial-in numbers:                     30-Day replay 
 Pass code for replays / conference   Pass code for replays / 
  ID: 68385863                         conference ID: 68385863 
 International Dial in: + 44          International Dial in: 
  (0) 2071 928000                      +44 (0) 1452 55 00 00 
 UK: 08445718892                      UK National Dial in: 08717000145 
 US: 16315107495                      UK Local Dial in: 08443386600 
 Austria: 019286559                   US Free Call Dial in: 1 
                                       (866) 247 4222 
 Belgium: 024009874 
 Czech Republic: 228881424 
 Denmark: 32728042 
 Finland: 0942450806 
 France: 0176700794 
 Germany: 030221531802 
 Hungary: 0614088064 
 Ireland: 014319615 
 Italy: 0687502026 
 Luxembourg: 27860515 
 Netherlands: 0207143545 
 Norway: 23960264 
 Spain: 914146280 
 Sweden: 0850692180 
 Switzerland: 0315800059 
 

Name of authorised official of issuer responsible for making notification:

Ketevan Kalandarishvili, Head of Investor Relations

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 35 hospitals and ten ambulatory clusters (consisting of 13 district ambulatory clinics and 28 express ambulatory clinics), as at 31 March 2017. GHG is the single largest market participant, accounting for 23.4% of total hospital bed capacity in the country, as of 31 March 2017. From January 2017, GHG become the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 29% market share based on 31 December 2015 revenue figures. GHG is also the largest provider of medical insurance in Georgia with a 35.3% market share based on net insurance premiums earned and approximately 135,000 insurance customers as at 31 March 2017. GHG employed a total of c.14,600 people as at 31 March 2017, including c.3,300 physicians.

For further information, please visit www.ghg.com.ge or contact:

 
      Nikoloz Gamkrelidze            Irakli Gogia                      Ketevan Kalandarishvili 
      CEO                            CFO                               Head of Investor 
                                                                        Relations 
      +995 322 550505                    +995 322 550505                  +995 322 550505 
       (5077)                             (5088)                           (5079) 
      ngamkrelidze@ghg.com.ge            irakligogia@ghg.com.ge            ir@ghg.com.ge 
 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOREFLBFDVFXBBQ

(END) Dow Jones Newswires

August 11, 2017 02:00 ET (06:00 GMT)

Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Georgia Healthcare Charts.
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Georgia Healthcare Charts.